Pages that link to "Q53574102"
Jump to navigation
Jump to search
The following pages link to Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. (Q53574102):
Displaying 50 items.
- Anabolic steroids for the treatment of weight loss in HIV-infected individuals (Q24245536) (← links)
- Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis (Q33222142) (← links)
- Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss (Q33330243) (← links)
- Androgen therapy in AIDS wasting (Q33637744) (← links)
- Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection? (Q33778748) (← links)
- Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions (Q33804521) (← links)
- Systemic manifestations of HIV infection (Q34056488) (← links)
- A practical guide to male hypogonadism in the primary care setting (Q34167760) (← links)
- Metabolic Complications of HIV and AIDS. (Q34207456) (← links)
- Nutrition in the era of highly active antiretroviral therapy (Q34255660) (← links)
- Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia (Q34294263) (← links)
- Neuroendocrine abnormalities associated with HIV infection (Q34381014) (← links)
- Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors (Q34457503) (← links)
- Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods (Q34540439) (← links)
- Nutrition and HIV infection (Q34564488) (← links)
- Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting (Q34774464) (← links)
- Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis (Q34985014) (← links)
- Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection (Q34998102) (← links)
- Androgen effects on body composition (Q35197853) (← links)
- Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients (Q35204837) (← links)
- Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels (Q35213002) (← links)
- Regulation of body composition by androgens (Q35667540) (← links)
- Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging (Q36130944) (← links)
- Treatment of Men for "Low Testosterone": A Systematic Review (Q36139976) (← links)
- Androgen deficiency and hormone-replacement therapy. (Q36185648) (← links)
- Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents (Q36271731) (← links)
- Diagnosis and management of testosterone deficiency (Q36293061) (← links)
- Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting (Q36417157) (← links)
- Androgen deficiency: effects on body composition (Q37141801) (← links)
- Effects of long-term testosterone administration in HIV-infected women: a randomized, placebo-controlled trial (Q37289326) (← links)
- Hypogonadism in human immunodeficiency virus-positive men. (Q37500129) (← links)
- Pharmacologic management of human immunodeficiency virus wasting syndrome (Q38208278) (← links)
- Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis (Q38241416) (← links)
- Testosterone and obesity (Q38485746) (← links)
- Development of models to predict anabolic response to testosterone administration in healthy young men. (Q40611725) (← links)
- Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels (Q42286790) (← links)
- Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry (Q42286793) (← links)
- Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration (Q42615663) (← links)
- Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial. (Q42848251) (← links)
- Gonadotrophic axis dysfunction in men with HIV-infection/aids (Q43176625) (← links)
- A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss (Q43674663) (← links)
- Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy (Q43758645) (← links)
- Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease (Q43758650) (← links)
- Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy (Q44030256) (← links)
- Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies (Q44361952) (← links)
- Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. (Q44387353) (← links)
- Oxandrolone does not improve outcome of ventilator dependent surgical patients (Q45023759) (← links)
- Prospective study of topical testosterone gel (AndroGel) versus intramuscular testosterone in testosterone-deficient HIV-infected men. (Q45143576) (← links)
- Position of the American Dietetic Association and Dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection (Q45741905) (← links)
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection (Q45747644) (← links)